Paper41575692
The purinergic signaling interfaces in breast cancer angiogenesis.
da Silva FC and 3 others. Purinergic Signal, 2026. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. The purinergic signaling interfaces in breast cancer angiogenesis. Papers, record 41575692. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41575692
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neovascularization, Pathologic | Major topic |
| Signal Transduction | Major topic |
| Breast Neoplasms | Major topic |
| Receptors, Purinergic | Major topic |
| Humans | |
| Female | |
| Animals | |
| Tumor Microenvironment |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 140350/2021-7 | Conselho Nacional das Fundações Estaduais de Amparo à Pesquisa | PubMed | ||
| 2024/07191-0 | Fundação de Amparo à Pesquisa do Estado de São Paulo | PubMed | ||
| REMITRIBIC RED-00031-21 and APQ-00741-24 | Fundação de Amparo à Pesquisa do Estado de Minas Gerais | PubMed | ||
| 405751/2023-0 and 305328/2022-0 | Conselho Nacional de Desenvolvimento Científico e Tecnológico | PubMed |
Source PubMed
References129
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34613483 | 3D tumor angiogenesis models: recent advances and challenges. | J Cancer Res Clin Oncol | 2021 | https://conductscience.org/library/papers/34613483 | PubMed |
| 2 | 36414127 | Unfolded protein response and angiogenesis in malignancies. | Biochim Biophys Acta Rev Cancer | 2023 | https://conductscience.org/library/papers/36414127 | PubMed |
| 3 | 24955090 | Breast Cancer Survival Defined by the ER/PR/HER2 Subtypes and a Surrogate Classification according to Tumor Grade and Immunohistochemical Biomarkers. | J Cancer Epidemiol | 2014 | https://conductscience.org/library/papers/24955090 | PubMed |
| 4 | 25542861 | Accelerated tumor progression in mice lacking the ATP receptor P2X7. | Cancer Res | 2015 | https://conductscience.org/library/papers/25542861 | PubMed |
| 5 | 27321181 | Extracellular purines, purinergic receptors and tumor growth. | Oncogene | 2017 | https://conductscience.org/library/papers/27321181 | PubMed |
| 6 | 32550907 | Herb-sourced emodin inhibits angiogenesis of breast cancer by targeting VEGFA transcription. | Theranostics | 2020 | https://conductscience.org/library/papers/32550907 | PubMed |
| 7 | 19926395 | Purinergic mechanisms in breast cancer support intravasation, extravasation and angiogenesis. | Cancer Lett | 2010 | https://conductscience.org/library/papers/19926395 | PubMed |
| 8 | 34703878 | Defueling the cancer: ATP synthase as an emerging target in cancer therapy. | Mol Ther Oncolytics | 2021 | https://conductscience.org/library/papers/34703878 | PubMed |
| 9 | 30345906 | Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer. | N Engl J Med | 2018 | https://conductscience.org/library/papers/30345906 | PubMed |
| 10 | 38239196 | Recent advances of anti-angiogenic inhibitors targeting VEGF/VEGFR axis. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/38239196 | PubMed |
| 11 | 21925313 | Basic and therapeutic aspects of angiogenesis. | Cell | 2011 | https://conductscience.org/library/papers/21925313 | PubMed |
| 12 | 31422497 | Ki-67 (30-9) scoring and differentiation of Luminal A- and Luminal B-like breast cancer subtypes. | Breast Cancer Res Treat | 2019 | https://conductscience.org/library/papers/31422497 | PubMed |
| 13 | 24335194 | Purinergic signaling and blood vessels in health and disease. | Pharmacol Rev | 2014 | https://conductscience.org/library/papers/24335194 | PubMed |
| 14 | 26071880 | Established breast cancer risk factors and risk of intrinsic tumor subtypes. | Biochim Biophys Acta | 2015 | https://conductscience.org/library/papers/26071880 | PubMed |
| 15 | 17823293 | Disordered purinergic signaling inhibits pathological angiogenesis in cd39/Entpd1-null mice. | Am J Pathol | 2007 | https://conductscience.org/library/papers/17823293 | PubMed |
| 16 | 18351132 | Adenosine modulates cell growth in the human breast cancer cells via adenosine receptors. | Oncol Res | 2007 | https://conductscience.org/library/papers/18351132 | PubMed |
| 17 | 22143354 | Perspectives of purinergic signaling in stem cell differentiation and tissue regeneration. | Purinergic Signal | 2012 | https://conductscience.org/library/papers/22143354 | PubMed |
| 18 | 34274385 | Cancer-cell-biomimetic Upconversion nanoparticles combining chemo-photodynamic therapy and CD73 blockade for metastatic triple-negative breast cancer. | J Control Release | 2021 | https://conductscience.org/library/papers/34274385 | PubMed |
| 19 | 29963134 | Tumor angiogenesis and anti-angiogenic gene therapy for cancer. | Oncol Lett | 2018 | https://conductscience.org/library/papers/29963134 | PubMed |
| 20 | 9112687 | Purinergic receptors. | Pol J Pharmacol | 1996 | https://conductscience.org/library/papers/9112687 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42584761 | Computational techniques to study breast cancer scaffolds for antiangiogenesis: a review. | J Mol Model | 2026 | https://conductscience.org/library/papers/42584761 | PubMed |
| 42548817 | Neuroimmune regulation of post-traumatic bone regeneration: focus on inflammatory switching and functional recovery. | Front Immunol | 2026 | https://conductscience.org/library/papers/42548817 | PubMed |
Genes69
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41575692
GET https://conductscience.org/api/papers/v1/41575692/references?page=2